tiprankstipranks
Cynata Therapeutics Limited (AU:CYP)
ASX:CYP
Holding AU:CYP?
Track your performance easily

Cynata Therapeutics Limited (CYP) Share Price & Analysis

5 Followers

CYP Stock Chart & Stats


Financials

Annual

CYP FAQ

What was Cynata Therapeutics Limited’s price range in the past 12 months?
Cynata Therapeutics Limited lowest share price was AU$0.10 and its highest was AU$0.34 in the past 12 months.
    What is Cynata Therapeutics Limited’s market cap?
    Currently, no data Available
    When is Cynata Therapeutics Limited’s upcoming earnings report date?
    Cynata Therapeutics Limited’s upcoming earnings report date is Feb 20, 2025 which is in 87 days.
      How were Cynata Therapeutics Limited’s earnings last quarter?
      Cynata Therapeutics Limited released its earnings results on Aug 29, 2024. The company reported -AU$0.029 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.029.
        Is Cynata Therapeutics Limited overvalued?
        According to Wall Street analysts Cynata Therapeutics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cynata Therapeutics Limited pay dividends?
          Cynata Therapeutics Limited does not currently pay dividends.
          What is Cynata Therapeutics Limited’s EPS estimate?
          Cynata Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Cynata Therapeutics Limited have?
          Cynata Therapeutics Limited has 180,801,270 shares outstanding.
            What happened to Cynata Therapeutics Limited’s price movement after its last earnings report?
            Cynata Therapeutics Limited reported an EPS of -AU$0.029 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.564%.
              Which hedge fund is a major shareholder of Cynata Therapeutics Limited?
              Currently, no hedge funds are holding shares in AU:CYP
              ---

              Cynata Therapeutics Limited Stock Smart Score

              Company Description

              Cynata Therapeutics Limited

              Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which has branded Cymerus.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cynata Therapeutics Limited
              Genetic Technologies
              Capricor Therapeutics
              Novartis
              Alnylam Pharma
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis